Philosys, Inc. Receives FDA Approval for Gmate® VOICE Blood Glucose Meter

Gmate® VOICE, the speaking meter that looks and feels like a smartphone

Online PR News – 18-March-2013 – NEW YORK, NY – Philosys, Inc. announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Gmate® VOICE Blood Glucose Monitoring System. With its sleek modern design and large 2.5” screen, the Gmate® VOICE has the look and feel of a smartphone. “This meter is designed to connect diabetics in many new ways due to its intuitive smartphone-like interface,” says James Winchester, Director of Marketing for Philosys. “We are confident this design advance will become the standard for all new meters,” Mr. Winchester elaborated.

says James Winchester Director of Marketing for Philosys.

Designed for diabetics, the Gmate® VOICE uses Real Voice Technology to clearly announce blood glucose readings. The Gmate® VOICE also offers the world’s largest memory to keep track of blood glucose levels over time. In the United States, the Gmate® VOICE will be available in English and Spanish (additional languages available for appropriate markets).

Philosys continues to make major advances in diabetic technology with the introduction of the Gmate® SMART Meter. With this new innovative technology, diabetics will be able to obtain their blood sugar levels right from their iPhone, iPad or iPod devices. Gmate® SMART has CE Mark approval and is currently available in Europe, Middle East, Asia, Africa and Latin America.

Philosys continues to move forward in their commitment to providing innovative health solutions to diabetics around the world.

For more information about the Gmate® VOICE and Gmate® SMART blood glucose monitoring systems, please visit or contact

Philosys, Inc.
New York, NY 10010 USA

visit our website